Aurinia Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.About AUPH
Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
AUPH Key Statistics
Stock Snapshot
As of today, Aurinia Pharmaceuticals(AUPH) shares are valued at $14.74. The company's market cap stands at 1.96B, with a P/E ratio of 7.26.
On 2026-03-05, Aurinia Pharmaceuticals(AUPH) stock traded between a low of $14.52 and a high of $15.24. Shares are currently priced at $14.74, which is +1.5% above the low and -3.3% below the high.
The Aurinia Pharmaceuticals(AUPH)'s current trading volume is 1.6M, compared to an average daily volume of 1.3M.
During the past year, Aurinia Pharmaceuticals(AUPH) stock moved between $6.83 at its lowest and $16.54 at its peak.
During the past year, Aurinia Pharmaceuticals(AUPH) stock moved between $6.83 at its lowest and $16.54 at its peak.
AUPH News
Aurinia Pharmaceuticals ((AUPH)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 70% Off TipRanks Premium Unlock hedge fund-le...
Analyst ratings
57%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.